INFRAFRONTIER is the European Research Infrastructure for Modelling Human Diseases
We contribute to human health by advancing disease prevention and therapies through appropriate models.
What does INFRAFRONTIER do?
In the INFRAFRONTIER consortium, more than 20 leading biomedical research institutes in 15 countries join forces to investigate the link between gene function and human diseases by the use of model organisms.
The Core Services of INFRAFRONTIER:
Develop precision mouse and rat models using the latest gene-editing tools – from electroporation and to CRISPR.
Phenotype the mutant models in a systemic way – in standardised pipelines as well as in specialised phenotyping studies defined individually by research partners.
Additional Resources that INFRAFRONTIER offers to the Life Science Community:
Axenic germ-free derivation of mice for microbiome research – GEMM-ESC archive for cancer models – COVID-19 therapeutics pipeline for novel treatments and vaccines.
Trainings & Workshops in model generation – cryopreservation – rodent biology and genetics – bioinformatics – Machine Learning.
Conferences & Meetings organised by INFRAFRONTIER and its scientific network partners.